September is leukemia, lymphoma and myeloma awareness month and the prelude to one of our busiest times of the year. But before we jump into the whirlwind of October events (our Light The Night Walks, the Leukemia Cup Regatta and the Nike Women’s Marathon), we would like to take a moment to acknowledge our dedicated partners who make it all possible.
Thanks to the generosity and support from individuals like YOU, remarkable progress has been made in treating patients with blood cancers, with survival rates for many having doubled or tripled, and in some cases quadrupled since LLS was founded in 1949.
Survival rates for children with acute lymphocytic leukemia (ALL), the most common childhood cancer, have risen over the past 40 years from 3% to approximately 90% today; Hodgkin lymphoma patient survival rates have doubled to 86% since the 1960s, and the five-year survival rate has increased from 25% in the mid-seventies to 41% for all myeloma patients, and patients diagnosed in the last decade had a 50% improvement in overall survival.
AND blood cancer research has become a gateway for other cancer treatments and cures:
- Forty-nine percent of the drugs approved by the FDA in the past 10 years for cancer were first approved to treat blood cancers.
- Many of these drugs are now being used to treat or are being tested to treat other cancers including breast, ovarian, lung, brain, liver, pancreatic and prostate cancers. This means your investment can go even further.
Your support empowers researchers to deliver life-saving results. Thank you for being part of the LLS family and helping create a world without blood cancer!
October is filled with LLS events. Learn more about how you can get involved at www.lls.org/sf.